Vonoprazan-Based Regimen Is More Useful than PPI-Based One as a First-Line Helicobacter pylori Eradication: A Randomized Controlled Trial - Matsuda, Yoshiaki; Wada, Shuichi; Horiuchi, Akira; Kiyosawa, Kendo; Fujisawa, Toru; Imai, Ryujiro; Tokutake, Koujiro; Kimura, Takefumi; Miyajima, Masayuki; Kubota, Daisuke; Tanaka, Naoki; Maruyama, Masafumi; et al. (Canadian journal of gastroenterology & hepatology, 2017)
Keywords: Acids; Adult; Aged; Aged, 80 and over; Amoxicillin - therapeutic use; Antacids; Anti-Bacterial Agents - therapeutic use; Antibiotics; Clarithromycin - therapeutic use; Clinical Study; Clinical trials; Comparative analysis; Drug therapy; Drug Therapy, Combination; Female; Gastric cancer; Gastroenterology; Helicobacter infections; Helicobacter Infections - drug therapy; Helicobacter pylori - drug effects; Hospitals; Humans; Japan; Lansoprazole - therapeutic use; Male; Metabolism; Middle Aged; Potassium; Proton pump inhibitors; Proton Pump Inhibitors - therapeutic use; Pyrroles - therapeutic use; Rabeprazole - therapeutic use; Single-Blind Method; Sulfonamides - therapeutic use; Treatment Outcome; Ulcers